Yusuf Erzın

1.3k total citations
71 papers, 829 citations indexed

About

Yusuf Erzın is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Yusuf Erzın has authored 71 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 18 papers in Genetics and 17 papers in Epidemiology. Recurrent topics in Yusuf Erzın's work include Helicobacter pylori-related gastroenterology studies (20 papers), Inflammatory Bowel Disease (16 papers) and Gastrointestinal disorders and treatments (15 papers). Yusuf Erzın is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (20 papers), Inflammatory Bowel Disease (16 papers) and Gastrointestinal disorders and treatments (15 papers). Yusuf Erzın collaborates with scholars based in Türkiye, United States and United Kingdom. Yusuf Erzın's co-authors include Aykut Ferhat Çelık, Ahmet Dırıcan, Bekir Kocazeybek, İbrahim Hatemı, Sibel Erdamar, Ahmet Dobrucalı, Mustafa Aslan, Gülen Hatemi, Hafize Uzun and Vedat Köksal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Annals of the Rheumatic Diseases.

In The Last Decade

Yusuf Erzın

63 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuf Erzın Türkiye 16 436 182 170 123 123 71 829
Yoshitaka Ueno Japan 19 268 0.6× 546 3.0× 124 0.7× 42 0.3× 320 2.6× 62 1.3k
Alessia Grassi Italy 12 103 0.2× 148 0.8× 112 0.7× 129 1.0× 61 0.5× 20 623
Müjde Soytürk Türkiye 12 239 0.5× 220 1.2× 79 0.5× 55 0.4× 30 0.2× 33 707
Aliakbar Amirzargar Iran 18 243 0.6× 512 2.8× 114 0.7× 119 1.0× 83 0.7× 79 1.1k
Hanan Guzner‐Gur Israel 16 116 0.3× 235 1.3× 56 0.3× 23 0.2× 125 1.0× 24 812
Taku Kobayashi Japan 12 201 0.5× 361 2.0× 60 0.4× 65 0.5× 522 4.2× 41 903
Sílvia Helena Barem Rabenhorst Brazil 19 268 0.6× 115 0.6× 153 0.9× 115 0.9× 70 0.6× 89 1.0k
Enayat Nikoopour Canada 15 119 0.3× 341 1.9× 25 0.1× 73 0.6× 193 1.6× 22 659
Rauli Leino Finland 18 169 0.4× 184 1.0× 43 0.3× 255 2.1× 288 2.3× 41 1.1k
Andrew Ippoliti United States 22 685 1.6× 162 0.9× 125 0.7× 72 0.6× 540 4.4× 34 1.3k

Countries citing papers authored by Yusuf Erzın

Since Specialization
Citations

This map shows the geographic impact of Yusuf Erzın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuf Erzın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuf Erzın more than expected).

Fields of papers citing papers by Yusuf Erzın

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuf Erzın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuf Erzın. The network helps show where Yusuf Erzın may publish in the future.

Co-authorship network of co-authors of Yusuf Erzın

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuf Erzın. A scholar is included among the top collaborators of Yusuf Erzın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuf Erzın. Yusuf Erzın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Törüner, Murat, Haluk Tarık Kani, Vuslat Yılmaz, et al.. (2025). P1067 Comparison of AZA-Related Pancreatitis and AZA-Related GI Intolerance Based on Demographic Factors, Clinical Variables and HLA DQA1/DRB1 Alleles. Journal of Crohn s and Colitis. 19(Supplement_1). i1969–i1970.
2.
Akyüz, Filiz, Altay Çelebi, Yusuf Erzın, et al.. (2024). Functional Bowel Disorder Management in Routine Practice with Tips for Hot Topics: Expert Opinion Review. The Turkish Journal of Gastroenterology. 35(6). 423–439.
3.
Akyüz, Filiz, Osman Ersoy, Yusuf Erzın, et al.. (2023). Small Bowel Video Capsule Endoscopy Guidance in Practice: Expert Opinion Report. The Turkish Journal of Gastroenterology. 34(1). S2–S19. 3 indexed citations
4.
Erzın, Yusuf, et al.. (2023). The Effect of Adherence to Mediterranean Diet on Disease Activity in Patients with Inflammatory Bowel Disease. The Turkish Journal of Gastroenterology. 34(7). 714–719. 8 indexed citations
5.
Önal, Uğur, Murat Tuncer, İbrahim Hatemı, et al.. (2022). The Psychological Effects of COVID-19 Pandemic in Patients with Inflammatory Bowel Disease. The Turkish Journal of Gastroenterology. 33(5). 387–396. 1 indexed citations
6.
Demiryas, Süleyman, Bekir Kocazeybek, Mehmet Demırci, et al.. (2019). Helicobacter pylori-miRNA interaction in gastric cancer tissues: First prospective study from Turkey.. 42(4). 210–220. 4 indexed citations
7.
Atasoy, Deniz, Afag Aghayeva, İsmail Ahmet Bilgin, et al.. (2018). Predictive parameters of early postoperative complications in Crohn’s disease: Single team experience. The Turkish Journal of Gastroenterology. 29(4). 406–410.
8.
Erzın, Yusuf, et al.. (2016). Demographic characteristics of chronic pancreatitis patients in the era of endosonography: Experience of a single tertiary referral center in Turkey. The Turkish Journal of Gastroenterology. 27(3). 284–289. 2 indexed citations
9.
Erzın, Yusuf, Nurhan Demir, Fatih Kantarcı, et al.. (2015). P565. The Increased Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients is not Related To Inflammatory Load. Journal of Crohn s and Colitis. 9(suppl 1). S363–S363. 3 indexed citations
10.
Erzın, Yusuf, Nurhan Demir, Fatih Kantarcı, et al.. (2015). P566. Efficacy and safety of vedolizumab with advancing age in patients with ulcerative colitis: Results from the GEMINI 1 study. Journal of Crohn s and Colitis. 9(suppl 1). S363–S364. 1 indexed citations
11.
Sayi‐Yazgan, Ayca, et al.. (2015). The cytokine response in THP-1 (monocyte) and HL-60 (neutrophil-differentiated) cells infected with different genotypes of Helicobacter pylori strains. The Turkish Journal of Gastroenterology. 26(4). 297–303. 9 indexed citations
12.
Avşar, Erol, Arzu Tiftikçi, Şule Poturoğlu, et al.. (2013). A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazolebased triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. The Turkish Journal of Gastroenterology. 24(4). 316–321. 8 indexed citations
13.
Hatemı, İbrahim, et al.. (2012). Endosonography-assisted transmural endoscopic drainage of pancreatic pseudocysts: A single center experience. The Turkish Journal of Gastroenterology. 23(6). 741–746. 2 indexed citations
14.
Yılmaz, Mesut, et al.. (2012). Prospective observational study on antibiotic-associated bloody diarrhea. European Journal of Gastroenterology & Hepatology. 24(6). 688–694. 11 indexed citations
15.
Akyüz, Ümit, et al.. (2011). Is propofol sedation with midazolam induction safe during endoscopic procedures without anesthesiologist?. PubMed. 57(101). 685–7. 7 indexed citations
16.
Akyüz, Ümit, et al.. (2010). Diagnosis of gastrointestinal stromal tumors with double-balloon enteroscopy. The Turkish Journal of Gastroenterology. 21(1). 39–41. 2 indexed citations
17.
Akyüz, Ümit, et al.. (2010). Severe odynophagia in a patient developing after azithromycin intake: a case report. Cases Journal. 3(1). 48–48. 4 indexed citations
18.
Aslan, Mustafa, Bekir Kocazeybek, Yusuf Erzın, et al.. (2010). Anti-Saccharomyces cerevisiae (ASCA) antibody levels in a subgroup of patients with ulcerative colitis, Crohn's disease, GI Behcet, and GI tuberculosis: Correlations with disease duration, activity, and extension. International Journal of Infectious Diseases. 14. e117–e118. 2 indexed citations
19.
Kocazeybek, Bekir, Mustafa Aslan, Yusuf Erzın, et al.. (2010). Clinical utility of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces Cerevisiae antibodies for discriminating specific intestinal inflammations. International Journal of Infectious Diseases. 14. e118–e118. 3 indexed citations
20.
Dinçer, Yıldız, et al.. (2007). Oxidative DNA Damage and Antioxidant Activity in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 52(7). 1636–1641. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Ueno Breakdown of academic impact, for papers by Alessia Grassi Breakdown of academic impact, for papers by Müjde Soytürk Breakdown of academic impact, for papers by Aliakbar Amirzargar Breakdown of academic impact, for papers by Hanan Guzner‐Gur Breakdown of academic impact, for papers by Taku Kobayashi Breakdown of academic impact, for papers by Sílvia Helena Barem Rabenhorst Breakdown of academic impact, for papers by Enayat Nikoopour Breakdown of academic impact, for papers by Rauli Leino Breakdown of academic impact, for papers by Andrew Ippoliti
Rankless by CCL
2026